We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Aurosling in Frontalis Sling Suspension Surgery

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00753831
First Posted: September 17, 2008
Last Update Posted: July 12, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Aurolab
  Purpose
To Study the Efficacy of Aurosling as a suspension material in Frontalis suspension surgery in ptosis

Condition Intervention Phase
Ptosis, Eyelid Procedure: Aurosling Phase 4

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Randomized, Double Blind, Active Controlled Study of the Efficacy, Surgical Outcome and Complications of Silicone Rod Sling in Frontalis Sling Suspension Surgery

Resource links provided by NLM:


Further study details as provided by Aurolab:

Primary Outcome Measures:
  • Ptosis Correction [ Time Frame: 15th day, 90th day postoperatively ]

Secondary Outcome Measures:
  • Adverse Events [ Time Frame: 15th day, 90th day postoperatively ]

Enrollment: 16
Study Start Date: January 2009
Study Completion Date: August 2009
Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Aurosling
Procedure: Aurosling
Silicon rod to be used in frontalis suspension surgery

Detailed Description:
Silicon rod is an effective and safe material used in frontalis suspension in treating ptosis with poor levator function.The elasticity and ease of adjustment of silicon rod are ideal characteristics for suspension material used to treat severe ptosis in patients with poor bells phenomenon. In the present study , we attend to study the efficacy of aurosling silicon material as a suspension material for frontalis sling surgery
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Congenital Ptosis
  • Severe Ptosis (MRD<0)
  • Poor levator function (<4mm by Berke's method)
  • Myogenic Ptosis (Myasthenia gravis)
  • Chronic progressive external ophthalmoplegia
  • Neurogenic Ptosis (Third cranial palsy)
  • Blepharospasm
  • Ptosis caused by trauma

Exclusion Criteria:

  • Acquired Ptosis
  • Horners syndrome
  • Blepharochalasis/Dermatochalasis
  • Mechanical Ptosis
  • Mild or Moderate Ptosis (MRD 1>1)
  • Good or fair levator function (>4 mm by Berke's method)
  • Previous Ptosis surgery
  • Ptosis associated syndromes/Other anomalies including
  • Marcus Gunn jaw winking syndrome
  • Blepharophimosis syndrome
  • Dry eye syndromes
  • Corneal anesthesia
  • Medical/Pediatric/Anesthesia condition contraindicating to surgery or anesthesia
  • Nystagmus where adequate measurements could not be done
  • Uncorrected vertical squint of any sort
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00753831


Locations
India
Aravind Eye Hospital
Madurai, Tamil Nadu, India, 625020
Sponsors and Collaborators
Aurolab
Investigators
Principal Investigator: Usha Kim, DO, Dip NB Aravind Eye Hospital, Madurai
  More Information

Responsible Party: Aurolab
ClinicalTrials.gov Identifier: NCT00753831     History of Changes
Other Study ID Numbers: 2PR1220827
First Submitted: September 16, 2008
First Posted: September 17, 2008
Last Update Posted: July 12, 2012
Last Verified: July 2012

Keywords provided by Aurolab:
Blepharoptosis
Ophthalmoplegia
Blepharospasm

Additional relevant MeSH terms:
Blepharoptosis
Eyelid Diseases
Eye Diseases